Shanghai Shen Lian Biomedical (SHSE:688098) Common Stock: ¥410.6 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688098 Shanghai Shen Lian Biomedical Corp SHSE:688098
70 GF Score
Price ¥8.41
GF Value ¥5.85
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Shanghai Shen Lian Biomedical Common Stock?

Shanghai Shen Lian Biomedical SHSE:688098 +0.48% 70 Common Stock is ¥410.6 Mil as of Mar. 2026. GuruFocus rates SHSE:688098 with a GF Score™ of 70/100 and a GF Value™ of ¥5.85 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Shanghai Shen Lian Biomedical's quarterly common stock stayed the same from Sep. 2025 (¥410.6 Mil) to Dec. 2025 (¥410.6 Mil) and stayed the same from Dec. 2025 (¥410.6 Mil) to Mar. 2026 (¥410.6 Mil).

Shanghai Shen Lian Biomedical's annual common stock stayed the same from Dec. 2023 (¥410.6 Mil) to Dec. 2024 (¥410.6 Mil) and stayed the same from Dec. 2024 (¥410.6 Mil) to Dec. 2025 (¥410.6 Mil).

Shanghai Shen Lian Biomedical Common Stock Historical Data

* Premium members only.

The historical data trend for Shanghai Shen Lian Biomedical's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Shen Lian Biomedical Common Stock Chart

Shanghai Shen Lian Biomedical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 410.64 410.64 410.64 410.64 410.64

Shanghai Shen Lian Biomedical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 410.64 410.64 410.64 410.64 410.64
SHSE:688098
70GF Score
Shanghai Shen Lian Biomedical Corp SHSE:688098
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Shen Lian Biomedical Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ¥410.6 Mil mean?
Shanghai Shen Lian Biomedical (SHSE:688098) has a Common Stock of ¥410.6 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Shanghai Shen Lian Biomedical and its competitors.
Is Shanghai Shen Lian Biomedical's Common Stock too high?
Shanghai Shen Lian Biomedical's current Common Stock is ¥410.6 Mil. Overall, Shanghai Shen Lian Biomedical has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Shen Lian Biomedical's Common Stock compare to VRTX and REGN?
Shanghai Shen Lian Biomedical's Common Stock of ¥410.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Shanghai Shen Lian Biomedical and its competitors. Shanghai Shen Lian Biomedical's current Common Stock is ¥410.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Shen Lian Biomedical stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Shen Lian Biomedical (SHSE:688098) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥5.85, compared to a current price of ¥8.41 — trading 43.8% above its estimated fair value. The current Common Stock is ¥410.6 Mil. Shanghai Shen Lian Biomedical's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Shanghai Shen Lian Biomedical (SHSE:688098), the current Common Stock is ¥410.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Shen Lian Biomedical (SHSE:688098) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Shen Lian Biomedical stock appears to be overvalued. The current stock price of ¥8.41 is trading 43.8% above its estimated GF Value™ of ¥5.85. GuruFocus considers Shanghai Shen Lian Biomedical to be Significantly Overvalued.

Key valuation signals for SHSE:688098:

  • Common Stock: ¥410.6 Mil
  • GF Value™: ¥5.85 vs. price of ¥8.41 (43.8% above fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688098 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Shen Lian Biomedical Business Description

Address No. 48, Jiangchuan East Road, Minhang District, Shanghai, CHN, 200241
Shanghai Shen Lian Biomedical Corp is engaged in the development, production and sales of veterinary biological products.
70GF Score

Get the complete analysis for SHSE:688098

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.41
Price
¥5.85
GF Value